SSKN STRATA Skin Sciences, Inc.
Healthcare · Market cap: $589
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $105.0K | $0 |
| 2022-Q2 | $27.0K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $1.1M | $0 |
| 2023-Q4 | $9.0K | $320 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $1.5M | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $7.0K | $18.8K |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$2.7M13 buy days
Sold$19.1K2 sell days
Net insider flow+$2.7Mnet buying · 5 years
Latest trade2025-11-18Rubinstein Samuel
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2025-11-18 | Buy | Rubinstein Samuel | Director | 5,000 | $1.41 | $7.0K | 2 |
| 2025-11-17 | Sell | Rubinstein Samuel | Director | 14,094 | $1.33 | $18.8K | 3 |
| 2024-07-15 | Buy | Accelmed Partners, L.P. | 10% owner | 230,573 | $3.14 | $724.0K | 1 |
| 2024-07-15 | Buy | Geiger Uri | Director | 230,573 | $3.14 | $724.0K | 1 |
| 2024-07-15 | Buy | Rafaeli Dolev | CEO | 19,100 | $3.14 | $60.0K | 1 |
| 2023-12-01 | Buy | Gov Shmuel | COO | 20,000 | $0.45 | $9.0K | 4 |
| 2023-11-16 | Sell | Rubinstein Samuel | Director | 1,000 | $0.32 | $320 | 1 |
| 2023-08-16 | Buy | 22NW Fund, LP | 10% owner | 1,853,056 | $0.55 | $1.0M | 1 |
| 2023-08-10 | Buy | Moccia Robert Joseph | CEO | 42,000 | $0.67 | $28.1K | 1 |
| 2023-08-10 | Buy | Lesovitz Christopher | CFO | 15,151 | $0.67 | $10.2K | 2 |
| 2022-06-15 | Buy | Rubinstein Samuel | Director | 1,050 | $1.04 | $1.1K | 1 |
| 2022-05-12 | Buy | Lesovitz Christopher | CFO | 23,131 | $1.12 | $25.9K | 1 |
| 2022-03-25 | Buy | Humphries William D. | Director | 16,950 | $1.73 | $29.3K | 1 |
| 2022-03-24 | Buy | Moccia Robert Joseph | CEO | 33,300 | $1.57 | $52.3K | 1 |
| 2022-03-24 | Buy | Humphries William D. | Director | 14,783 | $1.58 | $23.4K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| 22NW Fund, LP | 10% owner | $1.0M | $0 | 2023-08-16 |
| Accelmed Partners, L.P. | 10% owner | $724.0K | $0 | 2024-07-15 |
| Geiger Uri | Director | $724.0K | $0 | 2024-07-15 |
| Moccia Robert Joseph | CEO | $80.4K | $0 | 2023-08-10 |
| Rafaeli Dolev | CEO | $60.0K | $0 | 2024-07-15 |
| Humphries William D. | Director | $52.7K | $0 | 2022-03-25 |
| Lesovitz Christopher | CFO | $36.1K | $0 | 2023-08-10 |
| Rubinstein Samuel | Director | $8.1K | $19.1K | 2025-11-18 |
| Gov Shmuel | COO | $9.0K | $0 | 2023-12-01 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2024-07-15 | 3 | $1.5M | 64 | -22.6% (-26.6% raw) | -13.7% (-11.0% raw) | -20.2% (-16.5% raw) | closed |
| 2023-08-10 → 2023-08-16 | 3 | $1.1M | 59 | -12.3% (-14.9% raw) | -25.9% (-28.9% raw) | -43.7% (-35.6% raw) | closed |
| 2018-05-21 → 2018-06-14 | 4 | $138.0K | 42 | -12.0% (-11.4% raw) | +34.6% (+37.4% raw) | +41.2% (+28.0% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.